Archive by Author

FDA: Does Not Recommend Using Aspirin for Primary Prevention of Heart Attack or Stroke

Aspirin should not be used to prevent a first heart attack or stroke in patients with no history of cardiovascular disease, according to the U.S. Food and Drug Administration (FDA). In a statement released on May 5, 2014, the FDA said that its review of available data does not support the use of aspirin for […]

Leave a comment Continue Reading →

Antibiotics Linked to Increased Risks for Arrhythmia and Mortality

Azithromycin use has been associated with increased risk of death among patients at high baseline risk, but not for younger and middle-aged adults. The Food and Drug Administration issued a public warning on azithromycin, including a statement that the risks were similar for levofloxacin. Researchers conducted a retrospective cohort study among US veterans to test […]

Leave a comment Continue Reading →

New (2014) AHA/ACC Guideline for Management of Valvular Heart Disease

New, 2014 AHA/ACC, Guideline   for the Management of Patients With Valvular Heart Disease: has been   released.  This document is   a major revision of the 2006 and 2008 American College of Cardiology   (ACC)/American Heart Association (AHA) guidelines on the management of   patients with valvular heart disease. There are substantial changes in […]

Leave a comment Continue Reading →

Vitamin D deficiency Linked to Inflammation

An observational study published online on February 25, 2014 in the Journal of Clinical Endocrinology and Metabolism found that older, healthy individuals who were deficient in 25-hydroxy vitamin D (vitamin D) tended to have higher levels of biomarkers linked with CVD and inflammatory conditions such as multiple sclerosis and rheumatoid arthritis, in an observational study. […]

Leave a comment Continue Reading →

10 Key Points from the 2013 ESC Guidelines on the Management of Stable Coronary Artery Disease

10 Key Points from the 2013 ESC   Guidelines on the Management of Stable Coronary Artery Disease   These guidelines should be applied to patients with stable known or suspected coronary artery disease (SCAD). This condition encompasses several groups of patients: (i) those having stable angina pectoris or other symptoms felt to be related to […]

Leave a comment Continue Reading →

Cardiac Resynchronization may be harmful in narrow-QRS heart failure

Cardiac-resynchronization therapy (CRT) reduces morbidity and mortality in chronic systolic heart failure with a wide QRS complex. Mechanical dyssynchrony also occurs in patients with a narrow QRS complex, which suggests the potential usefulness of CRT in such patients. New data, from a randomized trial, presented at the European Society of Cardiology (ESC) 2013 Congress (also […]

Leave a comment Continue Reading →

Heavy coffee consumption linked with increased risk of all-cause death

Previous studies had suggested an association between heavy coffee consumption and all-cause mortality and coronary heart disease, but many of these older studies are compromised, because heavy coffee drinkers were also smokers, two habits that went hand in hand. When adjusted for smoking, the coffee didn’t appear to be very toxic, and most of the […]

Leave a comment Continue Reading →

Are ICDs Useful in Preventing SCD in Children and Adolescents with HCM?

Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in the young. The availability of  implantable cardioverter-defibrillators (ICDs) over the past decade for HCM has demonstrated the potential for sudden death prevention, predominantly in adult patients. In children and adolescents with hypertrophic cardiomyopathy , ICDs terminated life-threatening ventricular tachyarrhythmias, but frequently led […]

Leave a comment Continue Reading →

Does a closure of PFO prevent recurrent ischemic stroke?

  Whether closure of a patent foramen ovale is effective in the prevention of recurrent ischemic stroke in patients who have had a cryptogenic stroke is unknown. Two recently published multicenter studies have demonstrated no significant benefit of closure of a patent foramen ovale over medical therapy alone. Both studies were published in March 2013 […]

Leave a comment Continue Reading →

Carvedilol superior to Metoprolol in treatment of heart failure

In a study published on April 1, 2013 issue of the Journal of the American College of Cardiology, by Dr. Martin Ruwald (University of Rochester Medical Center, New York) and colleagues, comparing carvedilol to metoprolol in treatment of patients with heart failure reported that treatment with carvedilol was associated with a significant reduction in the […]

Leave a comment Continue Reading →